James D. Otvos,Irina Y. Shalaurova,Dennis W. Bennett,Justyna E. Wolak-Dinsmore,Thomas M. O'Connell,Kelly Mercier
申请号：
US16460269
公开号：
US20200005943A1
申请日:
2019.07.02
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Methods, systems and circuits evaluate a subject's risk of developing type 2 diabetes or developing or having prediabetes using at least one defined mathematical model of risk of progression that can stratify risk for patients having the same glucose measurement. The model may include NMR derived measurements of GlycA and a plurality of selected lipoprotein components of at least one biosample of the subject.
